Home › NDC Lookup › Ingredients › Menthol, Unspecified Form, Atropa Bellad... › 63936-9700-02
STOPAIN CLINICAL Migraine and Headache MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Gel, 1 g — NDC 63936-9700-02 package photo

STOPAIN CLINICAL Migraine and Headache MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Gel, 1 g

by Troy Manufacturing, Inc. · 1 g in 1 PACKET (63936-9700-2)
NDC 63936-9700-02
🏷️ FDA NDC (as labeled) 63936-9700-2 billing pads the package segment with a zero
This package
Contains1 g Pack sizes2 compare ↓
Also comes in: 12 packets 63936-9700-01
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 63936-9700-2
Product NDC 63936-9700
11-digit billing NDC 63936970002
UNII L7T10EIP3A, WQZ3G9PF0H, X43D4L3DQC, N9288CD508
SPL Set ID c5b690ce-7bb6-4840-b00b-205cd5bc6be6
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-07-01
Route TOPICAL
Dosage form GEL
Substance MENTHOL, UNSPECIFIED FORM; ATROPA BELLADONNA; IRIS VERSICOLOR ROOT; SANGUINARIA CANADENSIS ROOT
Why two NDCs? The FDA registers this code as 63936-9700-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 63936-9700-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerTroy Manufacturing, Inc.
Labeler code63936
First marketedJul 2018
Product typeHuman Otc Drug
Portfolio18 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

STOPAIN CLINICAL Migraine and Headache is a topical gel marketed as a homeopathic product. It contains menthol, atropa belladonna, iris versicolor root, and sanguinaria canadensis root in homeopathic dilutions. In homeopathic tradition, these ingredients are used for symptoms related to headaches and migraines. Homeopathic products are marketed based on traditional use and are not evaluated by the FDA for effectiveness or safety.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9XZ8H6N6OH
    A plant-based cellulose derivative used as a binder to hold tablet ingredients together, a thickener in liquids, and a coating agent to control how fast the medicine dissolves.
  • UNII 50C1307PZG
    Pentylene glycol is a humectant and preservative helper derived from petroleum or plant sources. It draws moisture into the product and helps prevent bacterial growth, keeping medicines stable during storage.
  • UNII 9O3K93S3TK
    Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAcrylic acid/vinyl ester copolymer, ethanol (USP), hydroxypropylcellulose, pentylene glycol, triethanolamine, water (USP)

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 packets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
STOPAIN CLINICAL Migraine and Headache 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/gthis 63936-9700-02 Troy 1 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2018
On the market since
Jul 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
63936-9700-01 12 PACKET in 1 BOX (63936-9700-1) / 1 g in 1 PACKET 2018-07-01 Active
63936-9700-02 You're viewing this 1 g in 1 PACKET (63936-9700-2) 2022-09-30 Active

Pack size FAQ

What quantity is in NDC 63936-9700-02?
NDC 63936-9700-02 contains 1 g — 1 g in 1 packet.
What is the difference between NDC 63936-9700-02 and NDC 63936-9700-01?
Both are STOPAIN CLINICAL Migraine and Headache MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Gel — the drug itself is identical. NDC 63936-9700-02 is the 1 g package, while NDC 63936-9700-01 is the 12 packets package.
What NDC number is used to bill for this package of STOPAIN CLINICAL Migraine and Headache MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g Gel?
Bill NDC 63936-9700-02 — the 11-digit billing format is 63936970002. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

STOPAIN CLINICAL Migraine and Headache MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT 1 [hp_X]/g; 3 [hp_X]/g; 6 [hp_X]/g; 6 [hp_X]/g GEL is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 63936-9700-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 63936-9700-02, written without dashes as 63936970002. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 63936-9700-02, the first segment (63936) is the labeler code FDA assigned to Troy Manufacturing, Inc.; the middle segment (9700) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Troy Manufacturing, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 12 packets (63936-9700-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Troy Manufacturing, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 10 words ▾

Uses Temporarily relieves head pain associated with migraine and headache.

⏱️ Dosage and Administration 59 words ▾

Directions • Adults and children over 12 years: Tear open packe • Dispense product onto finger tips • Apply to back of neck and behind each ear until product is absorbed • Use entire contents of packet • For best results, apply as soon as you feel discomfort • If after 30 minutes the symptoms persist, apply second packet

⚠️ Warnings 173 words ▾

Warnings For external use only. This product should not be used topically on children younger than 2 years of age nor should it be applied on any mucus membranes of any age child or adult. Seek the advice of your healthcare professional before using this product topically on children 2-12 years of age.

Avoid contact with eyes. If gel gets in eyes or on muscus membranes flush with cool water for 1-2 minutes Ask a doctor before use if you have never had migraines diagnosed by a health professional • Do not apply to broken or irritated skin • Do not apply to forehead or temples Keep out of reach of children. If swallowed, get medicial help or contact a Poison Control Center.

Stop use and consult a doctor if • condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few days • redness is present • excessive irritation of the skin occurs If pregnant or breast feeding ask a health professional before use.

🧪 Active Ingredient 27 words ▾

Active Ingredients Mentholum 1X HPUS-60.00% Belladonna 3X HPUS-1.33% Iris Versicolor 6X HPUS-1.33% Sanguinaria Canadensis 6X HPUS-1.33% Purpose Frontal Headache Temple/Occiput Pain Sick Headache Back of Head Pain

🧪 Inactive Ingredients 14 words ▾

Inactive Ingredients: Acrylic acid/vinyl ester copolymer, ethanol (USP), hydroxypropylcellulose, pentylene glycol, triethanolamine, water (USP)

🎯 Purpose 11 words ▾

Purpose Frontal Headache Temple/Occiput Pain Sick Headache Back of Head Pain

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 63936-9527-01 · Troy 63936-9750-01 · Troy →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.